Healthcare • Medical Devices
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if NNOX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
13 top institutions tracked
Sentiment: bullish
Last trade: buy 28 days ago
Red flags: 2
102 filers reported a long position in NNOX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| UBS Group AG | $1.7M | 1.5M | +9.5% |
| ARK Investment Management LLC | $935.7K | 806.6K | +10% |
| MARSHALL WACE, LLP | $903K | 778.4K | New |
| MORGAN STANLEY | $759.6K | 654.8K | +37.5% |
| BlackRock, Inc. | $691.4K | 596K | -84.4% |
| AQR CAPITAL MANAGEMENT LLC | $650.3K | 560.6K | +13.3% |
| BANK OF AMERICA CORP /DE/ | $529.9K | 456.8K | -5.7% |
| GOLDMAN SACHS GROUP INC | $404.3K | 348.6K | -8% |
| HRT FINANCIAL LP | $383K | 330.2K | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $377.4K | 325.3K | +228.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.